There is currently a national shortage of STI collection kits for APTIMA testing. This shortage will affect APTIMA testing for Chlamydia, Gonococcus, Trichomonas and Mycoplasma Genitalium (MGen). Spectrum Health Laboratories does offer alternative collection devices and testing for Chlamydia, Gonococcus and Trichomonas.
Advanced Technology Laboratory
Please refer to the below for Herpes Simplex Virus (HSV) orders:
Effective immediately, due to low test utilization and the high cost of maintaining proficiency, the Chromosome Analysis Breakage Study will no longer be offered by the Spectrum Health Cytogenetics Department.
If need arises for this test, please place an order for a Reference Miscellaneous (EPIC# LAB848) and enter “Test 140 DEB Breakage Study to Integrated Genetics” in the comments. The testing will be sent out through Spectrum Health Referrals Department to Integrated Genetics.
New posts will appear below this post.
If you are PATIENT requiring COVID-19 testing or information, please refer to the Spectrum Health COVID-19 Information Page: https://www.spectrumhealth.org/covid19
The following information is for PROVIDERS and CLINICIANS that wish to order COVID-19 testing: https://lab.spectrumhealth.org/covid-19/
As of November 25th 2019 the following tests for Herpes Simplex Virus (HSV) IgM antibody testing will be obsoleted.
Herpes IgM Antibody Screen – LAB3576
Herpes Simplex Panel – LAB1230539
Effective Wednesday, November 13, 2019, the new Mycoplasma genitalium (mgen) assay is now available using the Aptima target nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium to aid in the diagnosis of M. genitalium urogenital infections in male and female patients.